<DOC>
	<DOCNO>NCT01211431</DOCNO>
	<brief_summary>The goal compare quality post-cesarean analgesia , side effect incidence residual scar pain obtain intrathecal morphine ( reference treatment ) continuous intra-wound solution include ropivacain diclofenac ( experimental treatment ) .</brief_summary>
	<brief_title>Post-cesarean Pain Control Via Continuous Infusion Ropivacain et Diclogenac Into Wound Versus Intathecal Morphine</brief_title>
	<detailed_description />
	<mesh_term>Morphine</mesh_term>
	<criteria>single , normally progress pregancy term &gt; 36 week amenorrhea BMI 20 25 kg/m^2 pregnancy height 55 90 kg cesarean section JoelCohen Pfannenstiel techniques patient sign consent patient social security coverage Multiple pregnancy pathological pregnancy : hypertension ( &gt; 140/90 mmHg find pregnancy ) , preeclampsia , gestational diabetes term &lt; 36 week amenorrhea nonpregnancy related maternal pathology ( insufficiency ) obesity ( BMI &gt; 25 kg/m^2 pregnancy ) height &lt; 155 cm &gt; 180 cm weight &lt; 55 kg &gt; 90 kg patient refuse sign consent surgical technique JoelCohen Pfannenstiel hepatic insufficiency ( prothrombin &lt; 60 % ) contraindication rachianesthesia : infection , hemostasis problem ( platelet &lt; 80.109/L , prothrombin &lt; 60 % , TCA &gt; 40 ) allergy local anesthestics patient participate another study , participate another study within last 6 month patient type guardianship</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>cesarean section</keyword>
	<keyword>pain</keyword>
	<keyword>ropivacain</keyword>
	<keyword>diclofena</keyword>
	<keyword>morphine</keyword>
</DOC>